The global clinical
microbiology market size is expected to reach USD 16.7 billion by
2025, according to a new report by Grand View Research, Inc. It is projected to
expand at a CAGR of 6.7% over the forecast period. Clinical microbiology
depends on technical and skilled workforce to process and interpret results of
clinical specimens. Clinical staff have been complaining about poor Turnaround
Time (TAT) of tests. However, with technological advancements, a number of
laboratory instruments and equipment are being replaced with automated devices
to minimize human error and dependency on skilled workforce.
In addition, automation has benefits such as reduced
TAT and use of labor and lab space, thereby reducing overall cost associated
with these tests. Manufacturers are focusing on introduction of automatic
specimen processing, plate reading, and organism identification. GE Healthcare,
PerkinElmer, and Thermo Fisher are some of the key players offering automated
systems in the diagnostics industry.
Rising cases of hospital-acquired infections (HAI) is
also fueling demand for clinical microbiology for diagnosis and monitoring. As
high-income countries are stepping up their pursuit of countering
hospital-acquired infections, middle- and low-income countries are recognizing
the threat. Introduction of automated systems and innovative designs is
expected to intensify market competition and change market dynamics over the
forecast period.
The World Health Organization (WHO) is particularly
active in countries such as Ethiopia, Burkina Faso, Nigeria, Algeria, and
Senegal, where occurrence of HAIs ranged between 2.5% and 14.8%. This has led
to increased demand for HAI diagnostics in these countries. Countries such as
India, Sri Lanka, Pakistan, and Bhutan are also actively participating in HAI
awareness programs. India and China are projected to be the main countries driving
demand for HAI diagnostics instruments and tests in future.
Browse full research report on Clinical Microbiology Market: www.grandviewresearch.com/industry-analysis/clinical-microbiology-market
Further
key findings from the study suggest:
- Owing to rapid adoption of technology and automation of work flow,
laboratory instruments are expected to form the fastest growing segment
over the forecast period
- Reagents captured the largest revenue share in 2016 owing to repeat
purchase of reagents
- In 2015, North America dominated the global market. Continuous
research on infectious disease treatment and subsequent grants from
government healthcare agencies are contributing to development of a strong
ecosystem in the region
- Asia Pacific is expected to emerge as the fastest growing region
during the forecast period owing to rising geriatric population in India,
China, and Japan. This has resulted in high prevalence of re-emerging
infectious diseases such as tuberculosis, cholera, and typhoid
- The clinical microbiology market is presently dominated by a few
key participants such as bioMerieux S.A.; Cepheid Inc.; Danaher
Corporation; and Bruker Corporation
- Other prominent players operating in the market include Becton
Dickinson & Company; Hologic Inc.; Roche Diagnostics; and Alere Inc.
Browse more reports of this category
by Grand View Research: https://www.grandviewresearch.com/industry/medical-devices
Grand
View Research has segmented the global clinical microbiology market on the
basis of product, application, and region:
Clinical
Microbiology Product Type Outlook (Revenue, USD Million, 2014 - 2025)
- Laboratory
Instruments
- Incubators
- Gram
Stainers
- Bacterial
Colony Counters
- Autoclave
Sterilizers
- Petri Dish
Fillers
- Automated
Culture Systems
- Microbiology
Analyzers
- Molecular
Diagnostic Instruments
- Microscopes
- Mass
Spectrometers
- Reagents
Clinical
Microbiology Application Type Outlook (Revenue, USD Million, 2014 - 2025)
- Respiratory
Diseases
- Bloodstream
Infections
- Gastrointestinal
Diseases
- Sexually
Transmitted Diseases
- Urinary Tract
Infections
- Periodontal
Diseases
- Other
Diseases
Clinical
Microbiology Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Asia Pacific
- China
- India
- Japan
- Latin America
- Mexico
- Brazil
- Middle East
and Africa
- South Africa
About Grand View
Research
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com
No comments:
Post a Comment